[Severe cytomegalovirus-associated protein losing gastropathy in an immunocompetent adult]

Rev Med Interne. 2023 Apr;44(4):195-198. doi: 10.1016/j.revmed.2022.12.006. Epub 2023 Jan 11.
[Article in French]

Abstract

Introduction: Clinical expression of cytomegalovirus (CMV) infection is numerous and depends on the immune status of the host. In immunocompromised patients, CMV disease corresponds to reactivation of the virus with tissue damage responsible for significant morbidity and mortality. In immunocompetent adults, primary CMV infection is usually asymptomatic but may rarely result in severe organ damage.

Observation: We report the case of a 28-year-old man, considered immunocompetent and without medical history, presenting with a primary CMV infection revealed by a severe protein-losing gastroenteropathy (serum albumin level: 18.9g/L). The CT scan showed a gastro-duodeno-jejuno-ileitis pattern. Upper intestinal endoscopy revealed diffuse ulcerated and congestive gastritis predominantly in the fundus. Histological analysis of the biopsies showed no viral inclusion and no immunohistochemical staining reaction, but a high viral load (5.61 log). Treatment was symptomatic associated with anticoagulation due to the major hypoalbuminemia. The patient slowly recovered, and normal clinical examination and blood tests were observed two months after the onset of symptoms.

Conclusion: Severe CMV organ involvement in the immunocompetent patient is very rare but potentially serious. Digestive involvement complicated by exudative enteropathy is possible. Evolution is usually favorable without the need for antiviral treatment.

Keywords: Cytomegalovirus; Cytomégalovirus; Enteritis; Entérite; Entéropathie exsudative; Gastrite; Gastritis; Protein-losing gastropathy.

Publication types

  • Case Reports
  • English Abstract

MeSH terms

  • Adult
  • Antiviral Agents / therapeutic use
  • Cytomegalovirus Infections* / complications
  • Cytomegalovirus Infections* / diagnosis
  • Cytomegalovirus*
  • Humans
  • Male
  • Stomach
  • Ulcer / drug therapy

Substances

  • Antiviral Agents